Home
 
Sitemap
 
Legal Statement
 
 
 
 
 
 
 
 
 
Home > Products > Tracleer® > > About Tracleer > Exercise capacity
 
Products
 
 
 
 
 
 
 
 
 
 
Tracleer®
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
About PAH
 
 
 
 
 
 
 
 
 
 
 
 
Clinical worsening
 
Exercise capacity
 
 
Haemodynamics
 
 
Special patient population
 
 
Dosing regimen
 
 
WHO functional class
 
 
Long-term outcomes
 
 
Safety information
 
 
Effective patient management
 
 
References
 
 
Links of Interest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zavesca®
 
 
 
Impact on exercise capacity

  • Tracleer®

    significantly improves exercise capacity

    • Mean treatment effect of  +77m in 6-minute walk test in the first randomized trial3
    • Mean treatment effect of +44 m in 6-minute walk test in Breathe-1 (figure 9)2

Figure 9: Tracleer significantly improves exercise capacity3


Last update: 11 Jul 2008